2004
DOI: 10.1016/j.ijrobp.2003.09.005
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and morbidity of arc-therapy radiosurgery for cerebral arteriovenous malformations: a comparison with the natural history

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
28
0

Year Published

2005
2005
2017
2017

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 71 publications
(31 citation statements)
references
References 36 publications
3
28
0
Order By: Relevance
“…Other studies revealed no protective role of partially obliterated AVMs. 5 The risk of hemorrhage after SRS persists as long as the nidus remains patent. The relative higher hemorrhage rate after combined treatment may be partially explained by the fact that nidus size and AVM volume were larger in the embolized group than in the nonembolized group.…”
Section: Discussionmentioning
confidence: 99%
“…Other studies revealed no protective role of partially obliterated AVMs. 5 The risk of hemorrhage after SRS persists as long as the nidus remains patent. The relative higher hemorrhage rate after combined treatment may be partially explained by the fact that nidus size and AVM volume were larger in the embolized group than in the nonembolized group.…”
Section: Discussionmentioning
confidence: 99%
“…On long-term follow-up, AVMs are obliterated in approximately 80% of patients who undergo radiosurgery. 6,7,10,13,15,16,19,[23][24][25]28,29,33,35,38 The results of radiosurgery, unlike those of microsurgery, may not fully manifest for many years after treatment. There is a risk of hemorrhage during the latency period between radiosurgery and obliteration, which may last up to 5 years.…”
Section: ©Aans 2013mentioning
confidence: 99%
“…Gamma knife radiosurgery (GKS) is accepted as an effective treatment modality for patients with a cerebral AVM 1,7,14,19,23) . The obliteration rate for cerebral AVMs at 3 years after GKS varies from 61.2 to 86.6%, mostly dependent upon the size of AVM and marginal dose 17,20,23) .…”
Section: Introductionmentioning
confidence: 99%